>CYP688A1 CYPA 
MDNIYQFQLIMMLLWVPLILSFPLLWIILYPLCICYFYKFKYGNKVYVLYF
PFLGQFKYRMDGLKFQKDVIYFKRNIAYNHPEVELIXTHIFSRPYFIFIKPE
NVKQMLYNYANHKKRTDEIFRD
IIACKGLVYAEGQEWKDQKREISNFFTFEQLSSKIPVIKTLIQDTLQYKENQRVNIIKQC
ARISLRAMQICFFNQMKDEQINGQHLSEEFQDLSRYFLYVNRKYLIRLHMVVQYIS
RSFFGIKSLSTMKSYFMTANEKKFLQRVYVVRNYINNLINNHQKGSEKDVFSILLREPLTEEVR
EQIIHQYVTFVFAGMDTT
SHSAGLSIYMLGKHPQIQQRLREELTKINFDEIDQKLINPLPLLNAFLNE
CLRTQTPSDGIIPRLAVKDHYVGQYLIKKDWYVDVGLQPMMTHPQYFHNHLEFNIERWLN
QSEPEAFLPLSYGPRNCLGQHLARIEIKLTLIYIIKTYKVILDDQTDLVMDYTFLYAPSD
DRLVKFIRI*

>CYP689A1 CYPE similar to CYP3
MFQFTILEIILYLVLLLVLLILKPLFLMLIM
KIKYGKKMHLMYFPLLGRIIEFSRGIKKHNDLLHFEKMIPQQHPGVEIVVSNTFLGLTHV
FFKTEHIKFILNNQDLYKKTSKVLFGEKMLYK ()
GLAFQDGEDWRLARNVLAKSFEFEQLRARIPLIKRLCEEKFSKVPEDEPIDIINISGNIV
GEVITQSFFSQSFKDLNGKTFLSELVDVMVGIISQYREAPIRSMSRT
FIFGTKDYPNWTISKVEQRLLARLQKVKDILSDSIKERQSMENKPADFLTAYINTI (1)
QQNPKLTEEHAIQQYIMLIFAGIDTTSNLFGACCYALSIHPEWQIKLREEVQKQYSTYEQLN
SDNINVSNQITNFINECMRMYTPVPYFIEREVKQDHKVGDYFLKKNSEVSLCLFPNNYDS
KNYKDPFTFNPDRWNQQGIDPFVFLPFSIGKRNCIGQHMALMELKCLLVYLLMNFEVNS
VGEKQVWTFKFVYTIQNEKFIKLKRIGK* 190

>CYP690A1 CYPF + CYPT 86% to CYPB
MNLLILSYLGYLILALIAXFVIAPIPKLLYYKIKYGSAVEIYYFPFIGLIGQILIDLVFRSDVFYSQK
RLVLKNNKVKLHISNDLKGGVHFTLIDPKLKKLVFFDQESYKKMEGMPFADTFADQGLLF
QNGKSWHKSRQMLTKHFTNQDLLVMVETLKQECKKLQLKDGPIDILTVLKQLTSTTITKT
FFGSENNEIADLGVQVNKNMEKIMLFLLNPLIVLRCFALKLNKSTTPSFLLS
SGEKAFLRELQAQKQRIISEIEQGIKKIKENQTLQDNILTTMCKEIINNNITKEEAVHQYFTLL
IAGIDTTSHIVKNFCYALGLHPEVQERLRKEINSHIQ*FDDLRPQQLSE
FKLLDNFINEAYRQYTAAPSLFNRIA
LKDIQLGEFTILKGQSMDLNMMMSHFDPSIFENPLKFDIDRWNSPVLDPYS
FTPFSAGPRNCIGQHLATLELKTLLIFLIMNFNLELNNGKIQLGLSNLYGPTRRDFLVLKNINKQL*

>CYP690A2 CYPB 27% identical to CYPA
MNLIILSYLGYAILALIAYLVIAPIP
KLLYYKIKFGSAVDIYYFPIIGLIGQIIIDLIFRKDAFYSQKRYVLKNNKLKLHISNDLK
GGVHFSLVDPKLKKLVFFDQESFKKMEGMPFAD
TFMDQGLLFQNGKSWHTSRQMLTKHFT
YQDLLVMVETLKQECKKLQLQDGPIDILTLLKQLTSTTITKAFFGSENNDVSDLGVEVN
KNMEKMMLFFLNPLIVLRCFALKLNKTTTPSFLLSSGEKAFLRELQAQKQRISSQIDNGI
KKIKENQTLQDNILTTMCKEIINNNITKEEAIHQYFTLLIAGIDSTSHVVKNFCYALGLYP
EVQERLRKEIQSQVQQFDDLRPQQLSQFKLLDNFINESYRHYTAVPSLFNRVALKDIQLG
EFTIQKGQSMDLNMMMSHFDPSIFENPLKFDIDRWNSPLLDPYSFNPFSAGPRNCIGQHL
ATLEMKTLLVYLILNYKLELNSGKIILGLANMYGPTRRDFLVLKNINKQL*

>CYP691A1 CYPG 84% to CYPC
MIYIILGILALIYFITQPLIVVIYFKIKYGKRVIIQYAPMLGLLRTLSQSRAINGDAFQALSVL
IKNNRQADILVTNLLFRPLIVFLKPNYYKIFMQQHEAYTKFPMIVDKRLVSKGMLMEGGAKWKQQ
RKLLGAHFEYNKLINLIPMINDVAEKKLSGLPNSIFPAMNLASSITGEVVLRAFFGEDIA
KLSLNGQDPSLCVTQLITRFGQLITESRFFQIKRALLEEKVFSLFPRKIEKDLFE
LNTVMLDHMKKAIKGRMEKLKNCKDFVHQDYLDVYLDAYLNKNDQMDPPITEDEILQQ
SITLYFAGTETTANLVTTACYFLAENPHLQQEIYQEILEILNGESIITAKHLQNLQ
KVTGFLMECLRLKPVAPMLISKKALQDVYIMDIFIKK (1?)
GWYVNYMVLSNAQNQNYFPNPKQIDITRWKSDGTLKDSTIDPFAFVPFSAGGRNCIGQ
YLALIESKIVISKILMKYKLKLNEKLIKTEWIAKITYGLSNQDYITWEAR

>CYP691A2 CYPC
MIYIIFGILALSYLITQPLLVVIYFKIRYGKRVIIQYAPMLGLLRTLSQSRAI
NGDAFEALSKRIGDNRQADILVTGLLFRPMIVFLKPKYYRIFMQQHQDYTKFP
MIVDKRLMTKGMIMEGGAKWLQQRRLLGTHFEYNKLINLIPMINDVAQRKLANLPNEVFP
AMNLASSITGEIVLKAFFGEDIAQLSLNGQDPSQCVTQLITRFGQLTTESRFFQIKRALLEEKV
FSLFPRKIEQDLYELNTVMLDHMKKAIKNRMEKLKNCKNIEHQDYLDVYLDVYLNK
NDSMDPPITEDEILQQSITLYFAGTETTANLVTTACYFLAENQLLQEEIYQEILEVLNGE
LIITAKHLQNLQRVAGFLMECLRLKPVAPMLISKQALKDLYIKDIFIKK (1)
GWYVNYMVLSNAQDQKYFSNPTQIDITRWKADGTLKDSTIDPFAFVPFSAGGRNCIGQYLAI
IESKIVISKILLNYKLXLNQKIAKAEWIAKFTYGLSNQDYITWEAR*

>CYP692A1 CYPW 42% TO CYPR ONLY 27BP BETWEEN GENES CYPR AND CYPW
MLLYIFIGLLILFIYFTCLRTYIKLILLK
LTLGNKAIIRFYPLTGDFAQIPKSNRIYGDGLKHFQKRVFDNPNVKFVLSNLMHE
PLIEIYDPEYYKEVFINHELYQRADVLYHE (2)
KFTSRGILYSEGQ
RFRQQRQILGNHFTYDKLKERMPKVNQVVIEKIKNQDINQLHQFLVDLTTEIVMRSFFGS
EALEFKLNGQSVPAEILELDEEMAAQNLFNPYVVLK
RLIFGRKGDKILPSPAQKHLNDRVDRLIDFIISQINKK
LSNQQNKGDYFLDIYVDAYLKQEKEFQIEILEICSMFITMFAAGSGT
SVALTMTLYFLGLEQEAQQEIRQQIVQV
LNGQTEVLDIHLQQLTKLTAFIQEMFRFKAPLFAPFIRKAKKTHYIKNLKIEKGTNVLVL
FAAPGWSNKHYDNPEKFDYKRWLNANPIKEDNGFVYMPFSAGMRNCIGQHMAQLNMKIIL
SHILMNYKITLDPKQQVRFPINFQIDVEPGNIIQFERIK*

>CYP692B1 CYPR 36% to CYPH
MICYFCLAGLAI
FLYVFVIHIFVKLMLLKLKHGKDVYISFIPLFGDYFFLQQSFKKYGXATEIFKQRCQKNP
NIKFVASNILNKIFLFVHDPEYYKQVLVNHENYTKVEILYHP (2)   
KLSSTSILFGEPQKVKQQRSLLGEAFTFEKLKQRTPIINQVLLEKLQKEDKTNVLDF
LTKTSSEIIIKXFFCKELQEIIVQGNDITTEMIDLITQLGDMQMNDLYVSIKLALLGRRS
FGLFPSKNEKQLDARIDRLIDGTLMPIIKNKIANYXPNQNSDFLDIYIHAYLNQKPNEPK
ITELELCXLFVSIVSAGTDTTSHQIAITLYYLGVERQAQEEIRQEILNVVGNEVDIQPQH
LGKLVLLNAFIQEAFRIKNTVIQPLTRIAKETHYIKNLKVEK (1)
GTYVAALTTAPSWNDKYFDDPNKFDYKRWLS
QRPIKEDNGYVFVPFSAGGRNCIGQHMAMMTMKIMIGQILRQYDVVVDPSVKVTFPLVLF
IQYSPQNLVQLKKRKE*

>CYP692B2P pseudogene of CYPR 50% identical
YFKKLSSTSIFFGEPQKVKQQRNLIVKTFGIEKLK (fs)
LKSRIPVINQ (fs)
VFEKLEQEDKSNVLKFLKKSSEIIIKLK (fs) no fs in FN0AA118AB07LP1
LQYIITTEIMIDLISFCNIVLR 
MKMNKFYVNIKLAYFGVREFG
XXXXXXXXXXXXXXXXXXXX
YMDISLDDHSKQQKEFQVLIFKICFIFITMFAAGS
SKSDIVLTMALYLLGSEKEAQQEIRKQILLVFNGQTEELE
IHLQQLTAFIKEIFRFKAPLFAPFIRAAKKTHY

>CYP693A1 CYPP 60% TO CYPD
MLNWILLLISVVAVYLLVNPLVTMMKLKMQFG
NAVYCKYFPIFGIIQVYRKSFKLTGNVHQWIMDIVAKHPEVKFVVANSINKPVIFIIDPE
YYKQIYLDHHLVTKHDQSGIKD (2)
FLLSGGLLFTEGPKWKQQRNLVGDHFLFQKLKARIPMINQVV 
KEKINGMPVAEKMFEFICTITGEVVIRSFFGVEAEGWKINGKEA
QIELGSIFAAFIKLRVTNFFVYFKQKILGVKSWQYXFKKEKEIMDRVTKIKQDIREVIFK
RRDKIKQQGNYQGSGDFLDVYLKIFMEQNVYSSDRIETDEIVSQFITLFLAGTDTTGALV
ANSLLFISENKQYLQELRNEVNNVIGNGEITPENINQLVFVESFLKEVMRLKP
SVVYPIARKAKQNLQIKDLHIKEGTILLLGNFLANLNSQNYDNPLEFNPRRWLQQ
QPIKQDNGFINIPFAAGGRNCIGQHMAMIEARIILAYLIRNYDIVRNPQVPKVQWPSRGT
QTYIPDNAVHLVKI*

>CYP693A2 CYPD + CYPS 59% TO CYPP
MIYKLMFLYFFLFLALIGTYLILRPLLIMIKLKVQFGKQVYF
YYIPILGVIQIYRSSAKKGNPQQWVIDIITKHPEVKLIVSNSVTKPVFIIVDPEYYKPLY
LDHHLLVKHDQSGIKEYIVILNISFLLSKGLLFAEGEKWKEQRSLLGDHFLFEKLKERIP
MMNQVTRDAINNKQTVDQVFQYICSITGGVVIRSFFGQEAEGWLINDKPAQIELGEILKS
FVLVRFSNFFIYFQIK
LLGMKSWDYCLKAEKEILTRVIKFKQDLNQIISKRKSKIEKEGRKWENGDFLDVYLNKLS
KSKDTQESYQYETEDIISQFITLFLAGTETTGALVSNSLLFLSENTSYLEELRNEAKSALVD
GQVTADSLKKLVQLECFLKEVMRLKPSVVHPIVRQPKSDIQIKDLFIKKGSYILLGSFLA
NINSNHYEKPLEFNPKRWLQSKPIQIDNGFVNIPFAAGGRNCIGQHMAMIEARIILAHVI
LNYDVIKNPELTKVNWLSRGIQTYLPDDAIRLKKLE*

>CYP694A1 CYPK 37% TO CYPH
MYIYIGIGVSLILLY
TLVIKPLISLLLIKIKFGKQAKIIFYPIVGDIMEIEGSFKKYNDHYESLRRY
FTENKDLKFILLNVFKTPLILIGDPEINKMIHQDHENYKKIDFLNNN (2)
SRLMGQGLLYQSGQKWKSQRKLLGKPFDYDKL
KARIPMMNQVVKQKLKNTYNNPLDLTRSIAGEVVIQTFFGQEAQDAQLNNREAQAEIV
ELFNDVAEAIYGSVYGFLKWMILGEKQW
KLFPNKLERDINRRIDELTQFARKVIDNRITSIKQEGFKK
NQDDFDFLDIHLQEFLGSKNESGITKDEIISQFITLFFAGTDTTSSVAAMCLFYLAQN
PDVYDALIKELENVVGDGDGDVLDQHLPKLQELNSFIWEVLRVRNPASGPLVRVAKQDL
VLKDLHIKKGWILMPANFVQQQTDKYFENFKEFDHKRFLKAQAIKEDNGYVNIPFSAGPRNCIGQ (0) 
HMALMEIKIILCHILKTFKVITVPDKIKDLKWRAKFLYFYEPLDCI*

>CYP694B1 CYPUa + CYPUb 45% to CYPH and CYPL 
MIFYIIIIFVFYVLYRIVLKPLIPLLILKLQFGKEAYLWYAPIWGLLKYNFRS
LKQNGDFLDDLRKRMRENPQVKILLTNFLDTPFINFVDSEYIKKMYLEYQNFPKFNLLRYD (2)
NLIDKGLLMTEGEEWRFQRTLLGLAFTFEKLKSRIPMINQTVKERCILDPKT
NSFDFISWITGEVVIHSFFGEIAKGLTINGKPGQVEIVKLVADIMLQRFKNAYTQIKLMI
LGNKGWRILATKKEKDINNRVDTLRNTVKQLIETRIQQLKGETEARKEKDKDQCFLDIYLCELLKQ
QNEGSK KNIDFEPVLQQFLTLFFAGTDTT
ATMTVTCLVYLAKYPDVQNELLEEIKDLMQDSDVQDTHLPKLVKMNAFIN (0) 
EVFRLKNPAFSPFVRLVQQDMQFL
XXXXXXGWMVVQXXXXXXLLNEHFSNPEVFDYKRWLTGQGAIQSDNGFVHIPFGAGGRNCI
GQHMAQMELKIILCHIIRKFQVSLNPDVQLKFGIRFLYGAEPDNCLIYKTRR*

>CYP694C1 CYPL 53% TO CYPH
MLSIYIALASLIIAIIYFLVLLPLIPLLKIKMQLGSKAALMFYPLSGLNKIFNDS
LAKERDLLKIINNQLKKNPQTVVILSNFIHKPVLVWTGAEYIKDIYLDHTSY
VKVDPFMVESIAQKGMVLSEGEAWKRQRKFLGTAFTFEKLTSRLPMINQVVEKV
SKSDPKTNLNQFTSRITGEVVIHSFFGDLAKGFQIEGKDAQIAIVEILSEIFLMPMNNPF
IQLKQMLFEYKSWSIFPTKKEKQLLKRISDFKQVIMAMIEKRIEQLKNQQIENQDKMVFL
DLYVTEYLKQQKENKQDMDAEEILHQFITLFFAGTDTTATTSGT
CLYYLAQFPEMQEEILKEVIEVVGEQGDIKEEHLNKLVRVNALIQEVLRLRNPAFSPVFR
TVRQDKQLLDVKMKKGWFSVAYHIGPGLLDKHFENAQEFDYKRWLNKGNVIKNDNGFIHI
PFAAGPRNCIGQHMAVMEVKMIVARLVRQYKITLNPEVKDITFGMKFLYCVEPDNCLLYE
ERNLQ*

>CYP694C2 CYPH 32% to CYPG
MWNIALVFLCLLIIATYIFIIRPLIPLLLLKAKLGDKAIFMFYPLFGFIGLFMKSI
KTKNDAMETVNAALRKNPKAKIILSNLLHKPCIMLTGSEYLKDALTEHQHYEKMNPFMID
SFIQTGLILSEGDRWKRQRMFLGQAFTFEKLKSRIQMMNQVVKEIVDKDP
KTNLNEFMSKITGEIVIKSXFGELAEGLRLEGKEAQVALIQLTTDINLIQFENPFVLI 
KSLIFKERMWDVLPTKQEKDIVRRVNEVRTKVKEIISRRIEQLQENPIQDEDKMVFLDLY
VTEYIKQQKQQQQLINVNEILHQFITLFFAGTDTTATTCGTCLYYLAQYPEIQTEILEEI
QEVAGLDEIKEQHLNKLVKINALVQEVLRFKNPAFATIFRIVKNDMQLQDLKLKKGWAV
VEMLNASSVQENYFENATEFNYKRWLNTTNIIKNDNGFIYIPFSAGQRNCIGQHMAMMEAKV
IIALIVRKYQIILNPEVKQIKFGIKFLQCVEPDNCLLFEKRL*

>CYP694C3 CYPM 61% TO CYPH 59% to CYPL 
MEPILIAIFSLIMLMV
YFLIIKPLVPLLLLKLQLGDKAILMFYPIFGFLGVLTKSIQINNDLMHSINHALRKNPKA
KVILSNHLTKPFIMLTGSEYIKDSFLDHHDYEKMNPXMIPSFLQKGLVMSEGESWKRQRK
FLGTAFTFEKLKSRLPMMNKVIEYISENDDKSH
LNDFMARITGXXVIRSFFGELVEGFQLEGKDAQVALIQLTGEISIMQLQSAYYFI
KYLLFKDRMFEVFPCKKEKEILRRVENIRMKLNELILKRIQQLKENPVQDQEKMVFLDLY
VTEYLKQQKQNEQQIDLEEILHQFITLFFAGTDTTATTSGTCLYYLAKYPEIQSEILEEV
NQVVGNADINEDNLNXLTKVNALIQEVLRL
RNPAFVTLFRTVKRDKQVQDIKLKKGWALVQMQNASSIQDSHFDNATEFNYKRWFDKGNV
VKNDNGYINIPFAAGPRNCIGQHMALMEAKIIIALLVRKYKILLNPDVQEVRFGVKFLQTV
EPDNCLFFKKRIQ*

>CYP694C4 CYPJ different gene 84% to CYPI 
IILSNFLNKPCIMFAGTEYLKQSYQDHDDFEKLDPFMLPSFMQKGLAMSEGENWKRQRKF
LAPAFTFEKLKSRLPMMN
QVVEDIAEKYYKTNLNDFMSRITGEIIVKSSFGKLGEGFQLEGKEAWVALTKLTGEISLI
MMDNLYAFVKSLLFGVKTWTILPTKQEKDVVRRVENVRIKLNELILNRVEQLKDSPVQDQ
DKMVFLDLYVTEYLKQKKQNEQQIDLEEILHQFITLFFAGTDSTATICGTCLYYLAKYPE
IQSEILEEVNEVIGNADINEDNLNKLIKVNALIQEVLRLRNPAFVTLFRTVKRDKQVQDI
KLKKGWALV 

>CYP694C5 CYPI + CYPV 72% to CYPM 88% to CYPJ
MLTLFIAIVIVLSLALFFIFIQ
PLVPLLLLKLKLGNKAIIRFNPILGFI
GIFMRSIKTNQDVTKSINVALRNNPRAKIILSN
FLNKPCIMFAGTEYLKQSYQDHDDFEKLDPFMLPSFIQKGLVMSEGENWKRQRKFLAPAF
TFEKXKSRLPMMNQVVEDIAEKDDKTNLNDFMSRITGEIVVKGFFGKLAEGFQLEGKDAQ
IALTNLTGEISLIVMENLYSFVKSLLFGVKMWKILPSKQEKDLVRRVENVRIKLNDLILK
RIEQLKDNPVQDQDKMVFLDLYVTEYLKQQAQNEQQIDLE
EILHQFITLFFAGTDTTATVCGTCLYYLAKYPEIQSEILEEVNEVIGNADINEDNLNKLI
KVNALIQEVLRLXXXXFVXXFRXVKXDKQVQXIK
LKKGWALVQMQNASSIQDTHFDNATEFNYKRWLSKDSIIKNDNGYIHIPFTAGPR
NCIGQHMALMEAKIIIALLIRKYKILLNPAVQQIRFGIKFFQCVEPDNCVLFEKRI*

>CYP695A1 CYPX 37% to CYPN 35% to CYPK 
MLFQILLILLGLLISWFVIK
PLVIMMKLKLQFGSTCKIQFGIFGILGLSSQSIIEKMKRKSIPKTVKFIVHNYASAVYIL
IIDPDYYQFMLNNHENYSQINDLNT (2)
SQLLDEGIMFQQGERWKQQRELLIQYFDIDKLKRNLPKLNEIIKQNFKQYDYQNDQIQT
TLLIIISDILIQSFFGQDANKLLINNKCIGLETTDLFEALSKLSRKPYSICKNILFGVQA
LKMFPSSEEQIIQTKINNIKFTIEKIIQKRIVQHELKLDEDENEISQMSEDI (fs?)
LIYIFEPIFKLKXXNNRMSFEEI
KQQYFTIFKIGSQTTNQIIQASLHYLAEQPQIQNELRQEILSICKTDIISYQE
LKSLVKLSAFLNEVLRFVNPIPIVRKVQTTHFIKDLKLKR (1)
NWVVMVDNSVT
NSSEKYYDNPKEFNYQRWLQSESIKENNNYVFIPFSNGPRNCVGQSLATMIYQIILINIL
RNFEVNVNEKSKNNKSITFVLQNSSFKLSPISQK*

>CYP696A1 CYPQ 47% TO CYPN
MIIYVLYAVLGLILYLFVMKPLTEMIKLKFQFGKECKICFTVFGKEIFDQLKETKENKNPRDIFNKQK
TAYNKYQYKFFVTNMLWIIRISIADPLYQKEALINHDLYQKVDPVCHN (2)
DLLSKGLVWSKGEQWKKQRKLLSSSFEFDALKKKVPMINEITQSKIEKFSNENV
LSSLQSITGLIVIKSFFGIQTDQIYI
NNTELQVEIANIMNEMAYMRFKSQIQSTKRLIFGTKAWKIFPTKEEKRLLQRVKDMRSIVGDLVQQRIKYFEDS
NNSKNNTINENFLNILVNEYLKITNKQQQEATFDQIIQEFITLQFAGTDTTAVLLHHCLY
FLASYPQAQDEIRGEVNRCCPSSFINENEINNLKRLSAFISEVLRLKNPAMRPIIRVATQ
DHKIKDLQIKK (1)
GWLVCIDYFLQNQSEKHFENAGQFDYTRWLQDS
PIKDDNNLIYIPFSAGPRNCIGSQMALL
EVKIILGQILKQYQITRNTNVEVSWEIHFNHQLSPTNAVILNKIK*

>CYP696B1 CYPYa + CYPYb 47% to CYPN 
MIIQIFAILIVLFFYVFVLKPLCPMIKLKMQFGQDCKMQYNFLGRDIWKRLRDLKI
FNDIFWSDKEEYKRLPYKFKVSNSFWKIQIQVADPEYYKQILHNPHYYEKANNXADK (2)
HLLQKGLVFETRDQWKAQRNILADQFQYQQLTSRLPMINKIILDGITKIGSANNLF
EQLELMTGKVVIQSPFGDSIDGLKVNNKDLQVEVTELINDMGESRFKSKYVFIKRLLLGT
WAWNIFPTQEEMMIQQRVFQLKTMIEKVIRKRLIELRQRNKQNDQKDLNLFLDILL
NDYIKNDHKKQESQAIDEVIQQFITLLFT
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX
LKQLIKLSALINEALRLKNPAVNLLMRNSTQTHQVKDLTIQK (1)
NWRVIVNFQF
QLLSEKNFKNPEDFDYKRWLTPSPILNNNNFVYLPFSAGQRNCIGQHMALMEAKIILSQI
LKQYYIKPNMNVNPMWNLRFILQLQPGNCMKL

>CYP696C1 CYPN 37% TO CYPH 
MIIHIILALFLLMFYLLVV
KPLVPMIKLKMQFGDACLMKYHLFGGELWEALKEMKTSKDLFKRHRDLYMNHPYKIFV
TNFLWKVRINVADPEYYKLMLTNHQYYSKFNNINH (2)
DNVIQNGLICQMGEK
WRAQRLLLSESFDYHQLKSRLPMINEVCLDKINSIHGENILEFLELITGQVVIRSFFGKSAD
GVQINKKKIQIEIADLLNELGEVRFKSKYLFVKRFFLGTKSWGFFPTNKEKELL
QRISEMRLAIEKLIQKRIVEIELKMDENEDEIKQRETDFLDV
LIKEYLKQKKQGTQKITIDEIIQQFITLFF
AGTDTTAVLSYHCLYYMAQYPEMQDEIREEVLTICKNESILDDKIKQLHKLSAFINEVLR
FKNPALRLMMRFCNQTHQVKDLTIQK (1)
GWSVTIDYQFPQWLPKHFPNPEKFD
YKRWLEKEPIKENHQFVYLPFSSGPRNCIGQHMALMEAKIILSQILRQYSIEINHD
VDSRWTARFLYQLQPGNCVKLQKR*